About
The transition of synthetic biology from academic confines to commercial implementation presents a formidable task. For synthetic biology to exert its profound influence, an escalation to industrial magnitude becomes imperative. This amplification journey is laden with challenges, encompassing aspects such as fermentation prowess, fiscal considerations, supply chain innovations, feedstock accessibility, and bioreactors' efficiency and design intricacies. Notwithstanding these hurdles, emergent technologies and methodologies are paving the way, poised to elevate the bioeconomy to unprecedented levels.
Speakers
Agenda
Agenda
Monday
May 05
Tuesday
May 06
Rewriting the Rules: Real-World Impact of Rapid, AI-Enabled Bioprocess Deployment
-
Today’s bioeconomy requires more than incremental improvements—it demands a fundamental shift in how bioprocesses are developed and scaled. This spotlight talk presents a real-world case study in which an AI-enabled continuous fermentation platform transformed a traditional process for a high-demand product. By integrating machine learning and continuous process optimization, the team achieved a threefold increase in productivity, cut unit costs by 50%, and developed a fully optimized process in just 100 days. This rapid approach enabled the partner to move from proof-of-concept to pilot scale within 10 months, meeting ambitious commercial goals with unprecedented speed and efficiency. The session will explore how combining AI and continuous fermentation creates nimble, scalable, and data-driven workflows—offering a blueprint for the next generation of biomanufacturing.
How Precision Fermentation CDMOs are Driving Global SynBio Adoption
-
Precision fermentation is one of the most significant technical breakthroughs for commercializing synthetic biology. Now experienced CDMOs are leveraging this technology along with advanced strain development and amino acid, nucleotide, and other feed and food ingredients production to scale diverse products across the biotech value chain. This talk will reveal the latest CDMO partner for the synbio industry. Leveraging over 70 years of experience and 11 production cites globally, this session will explore new scale-up capabilities, business cases, and how to bring innovative products to market.
Harnessing Light for Precision Manufacturing of Biopharmaceuticals
-
The latest generation of biologics are becoming increasingly difficult and costly to produce using conventional mammalian systems. These rely on constitutive “always on” expression of the target gene, which can overwhelm cellular machinery, limiting protein yield and driving up production costs —especially for complex or toxic proteins. These obstacles can be overcome using molecular optogenetics, a technology that employs genetically encoded, light-sensitive proteins to precisely control gene expression. By decoupling growth from production, cells can first reach high density before switching to efficient protein expression. Coupling this with closed-loop control enables the ability to dynamically tune protein expression to maximize titer, improving manufacturability. This session will discuss how the development of optogenetically-enabled cell lines and bioprocessing can be used to accelerate the production of next-generation biologics.
Blueprints for the Future: Effective Bio-Strategies for Biomanufacturing Scale-up
-
Scaling commercial biomanufacturing is a complex dance of science, strategy, and infrastructure. As demand for bioproducts surges, industry leaders are grappling with significant challenges in growing their operations and capacity without compromising quality, efficiency—and most importantly—cost. Now, key innovations are enabling large-scale enterprises to adopt biomanufacutring practices without compromise. This talk will address the unmet needs of the biomanufacturing sector through the use of drop-in replacement ingredients for everyday items and demonstrate actionable biostrategies for innovation at commercial scale.
Alt Feedstocks and AI: Fermentation Trends Solving SynBio’s Scaling Crisis
-
The bioeconomy cannot succeed without the feedstocks that fuel all our fermentors. From agricultural side-streams to algae to carbon pollution, synbio companies need to ensure they utilize renewable feedstocks instead of purpose-grown inputs that take essential land and, at scale, may drive deforestation. How can we address this critical issue as a community? What role do other innovations such as AI, sensors, and continuous fermentation play in accelerating sustainable scaling and what changes do we need to make today for the bioeconomy of tomorrow?
Accelerating Biomanufacturing Through On-Demand Synthesis
-
This innovative approach leverages nucleic acid development from Telesis Bio and protein production from the Illinois Biological Foundry for Advanced Biomanufacturing. These thought leaders will discuss the streamlined and enhanced efficiency of producing complex biological molecules when integrating their advanced technologies, transforming the landscape of synthetic biology.
Wednesday
May 07
Meet the Next-Gen of Revolutionary Fermentation and Large-Scale Biomanufacturing
-
Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of fermentation. Rather than waste money building fermentation capacity from scratch, companies can transform their biomanufacturing processes with external experts. By leveraging their collective experience and economies of scale, CDMOs can harness the power of engineered organisms to drive innovation and efficiency across diverse industries. By seamlessly integrating fermentation with cutting-edge synthetic biology techniques, these global facilities not only boost productivity but also promote environmental sustainability. Through decades of in-house knowledge, strategic industry collaborations, and an unwavering commitment to shaping the future of biotechnology, our leading team isn’t merely anticipating trends; we are actively creating them.
Maxing Bioprocesses At Scale By Targeting Heterogeneity – An Industry Perspective
-
Controlling cell-to-cell variations in fermentation tanks from lab-scale to large-commercial scale poses challenges but can create immense value, unleashing the full potential of the process. Recent advances in understanding and measuring fermentation heterogeneity have created a new focus on cell heterogeneity, and SynBio technologies to intelligently promote the best cell variants. Join us when leading industry experts discuss how mitigating cell-to-cell variation helps them unlock value in their fermentations and hear them share recent experience.
Continuous Fermentation – How Close Is It to Commercial Reality?
-
Continuous fermentation has significant potential to lower the cost of biomanufacturing, but how close to commercial reality is the technology? A group of industry experts will dig into the state of technology development and potential paths to implementation.
Thursday
May 08
Applied AI for Biomanufacturing: Challenges, Opportunities, and Real-World Impact
-
Artificial intelligence is already reshaping biomanufacturing, challenging long-standing practices and driving new levels of productivity. But what does this transformation look like in practice? This session offers a candid, hype-free discussion on the real-world impact of AI in biomanufacturing today. Industry experts will explore how AI is accelerating production, reducing costs, and enabling rapid scale-up—while also addressing the technical, organizational, and regulatory barriers that remain. Through real case studies and practical insights, we’ll examine what’s working, what isn’t, and what lessons can be drawn from current deployments. Join us for an honest look at the challenges, opportunities, and future direction of applied AI in the bioeconomy.
Downstream Recovery – The Tail That Wags the Dog
-
Fermentation has historically been the primary focus of most biotechnology organizations, however downstream recovery often represents a more significant contributor to manufacturing cost and capital requirements.